Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The fourth Oxford Centre for Haematology Day, held at the MRC WIMM on 28th January 2025, was a very successful afternoon. Talks covered some of the breadth of haematology research in Oxford.

Zoe accepting the OCH Doug Higgs Poster Prize from Dr. Curry.

The day had a focus on translational haematology with talks on wide-ranging topics such as transfusion medicine and big data, systematic review and meta-analysis, lymphoma clinical trials, organoids and their applicability across haematology, paediatric haematology, acute lymphoblastic leukaemia, immune microniches, and the Oxford Translational Myeloma Centre.

The day was finished with a talk from Dr Sue Pavord, President of the British Society for Haematology (BSH), with a talk on future plans for BSH research in the UK.

This year the OCH Doug Higgs Poster Prize was won by Zoë Wong (pictured above, receiving her award from Dr Nikki Curry) who presented her winning scientific abstract on 'Implementing human bone marrow organoids to interrogate microenvironmental influences on the efficacy of blood cancer immunotherapies'.

Well done Zoe, and congratulations also to the runner-up, Stephanie Taylor, who presented her clinical abstract on “Using evidence-based co-design to develop a virtual based exercise intervention that aims to increase confidence to exercise in persons with haemophilia”.

Similar stories

New bone marrow model offers scalable platform for next-generation drug discovery

Researchers at the MRC Weatherall Institute of Molecular Medicine have developed the first combined human bone and bone marrow organoid platform capable of modelling long-term blood and immune cell production in a fully human 3D system.